Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model.
Eggermont AMM, Bellomo D, Arias-Mejias SM, Quattrocchi E, Sominidi-Damodaran S, Bridges AG, Lehman JS, Hieken TJ, Jakub JW, Murphree DH, Pittelkow MR, Sluzevich JC, Cappel MA, Bagaria SP, Perniciaro C, Tjien-Fooh FJ, Rentroia-Pacheco B, Wever R, van Vliet MH, Dwarkasing J, Meves A.
Eggermont AMM, et al. Among authors: rentroia pacheco b.
Eur J Cancer. 2020 Nov;140:11-18. doi: 10.1016/j.ejca.2020.08.029. Epub 2020 Oct 5.
Eur J Cancer. 2020.
PMID: 33032086
Free PMC article.